Matches in SemOpenAlex for { <https://semopenalex.org/work/W1722003791> ?p ?o ?g. }
- W1722003791 endingPage "10" @default.
- W1722003791 startingPage "5904" @default.
- W1722003791 abstract "The prognostic value and therapeutic utility of monitoring the decay of alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) after chemotherapy for nonseminomatous germ cell tumors was assessed. Patients treated on successive front line chemotherapy protocols at Memorial Hospital between 1979 and 1988 were studied. Marker values taken within the first 90 days of treatment were reviewed for the 198 patients who had initially abnormal values and serial measurements at Memorial Hospital. Since markers frequently increased in an unpredictable fashion in the first week after chemotherapy, prechemotherapy values would be inaccurate for assessment of subsequent half-life. Therefore, the first two values measured greater than 7 days after the start of treatment were used for all calculations of half-life. Among 38 patients who had the two successive AFP measurements elevated, those who later achieved a complete response (CR) had a median AFP half-life of 6.1 days (n = 20), whereas those not achieving CR had a median AFP half-life of 13.3 days (P = 0.02). Among 37 patients with the two successive HCG values elevated, those who later achieved CR had a median HCG half-life of 4.2 days (n = 10), whereas those not achieving CR had a median HCG half-life of 18.4 days (P = 0.04). Forty-two patients who had an AFP half-life greater than 7 days or an HCG half-life greater than 3 days had significantly shorter overall survival (median, 8 months) than the other 156 patients (median not reached) (P less than 0.0001). These 42 patients also achieved CR in lower proportion (29%) than the other 156 patients (89%) (P less than 0.0001). Cox regression identified prolonged marker half-life as the most significant independent predictor of survival. Lack of appropriate decay of serum tumor markers can identify patients unlikely to achieve CR or prolonged survival and thus can be used to select patients during treatment who may benefit from an early change to more aggressive therapy." @default.
- W1722003791 created "2016-06-24" @default.
- W1722003791 creator A5000188760 @default.
- W1722003791 creator A5004913924 @default.
- W1722003791 creator A5013570742 @default.
- W1722003791 creator A5022647145 @default.
- W1722003791 creator A5062419531 @default.
- W1722003791 date "1990-09-15" @default.
- W1722003791 modified "2023-09-23" @default.
- W1722003791 title "Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors." @default.
- W1722003791 cites W153281004 @default.
- W1722003791 cites W1533936180 @default.
- W1722003791 cites W1610439870 @default.
- W1722003791 cites W1874791016 @default.
- W1722003791 cites W1889115263 @default.
- W1722003791 cites W1953186452 @default.
- W1722003791 cites W1961050161 @default.
- W1722003791 cites W1970781080 @default.
- W1722003791 cites W1975575552 @default.
- W1722003791 cites W1978973179 @default.
- W1722003791 cites W1979300931 @default.
- W1722003791 cites W1995726655 @default.
- W1722003791 cites W2039906289 @default.
- W1722003791 cites W2056059123 @default.
- W1722003791 cites W2061653183 @default.
- W1722003791 cites W2081247796 @default.
- W1722003791 cites W2094521253 @default.
- W1722003791 cites W2124980843 @default.
- W1722003791 cites W2139984188 @default.
- W1722003791 cites W2175965103 @default.
- W1722003791 cites W2256277554 @default.
- W1722003791 cites W2267740990 @default.
- W1722003791 cites W2416380208 @default.
- W1722003791 cites W2418209322 @default.
- W1722003791 cites W2796700885 @default.
- W1722003791 cites W581013490 @default.
- W1722003791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1697503" @default.
- W1722003791 hasPublicationYear "1990" @default.
- W1722003791 type Work @default.
- W1722003791 sameAs 1722003791 @default.
- W1722003791 citedByCount "38" @default.
- W1722003791 countsByYear W17220037912012 @default.
- W1722003791 countsByYear W17220037912013 @default.
- W1722003791 countsByYear W17220037912014 @default.
- W1722003791 countsByYear W17220037912015 @default.
- W1722003791 countsByYear W17220037912019 @default.
- W1722003791 countsByYear W17220037912022 @default.
- W1722003791 countsByYear W17220037912023 @default.
- W1722003791 crossrefType "journal-article" @default.
- W1722003791 hasAuthorship W1722003791A5000188760 @default.
- W1722003791 hasAuthorship W1722003791A5004913924 @default.
- W1722003791 hasAuthorship W1722003791A5013570742 @default.
- W1722003791 hasAuthorship W1722003791A5022647145 @default.
- W1722003791 hasAuthorship W1722003791A5062419531 @default.
- W1722003791 hasConcept C121608353 @default.
- W1722003791 hasConcept C126322002 @default.
- W1722003791 hasConcept C126894567 @default.
- W1722003791 hasConcept C141071460 @default.
- W1722003791 hasConcept C143998085 @default.
- W1722003791 hasConcept C2775948956 @default.
- W1722003791 hasConcept C2776694085 @default.
- W1722003791 hasConcept C2776938808 @default.
- W1722003791 hasConcept C2778019345 @default.
- W1722003791 hasConcept C2780624289 @default.
- W1722003791 hasConcept C2781447364 @default.
- W1722003791 hasConcept C71315377 @default.
- W1722003791 hasConcept C71924100 @default.
- W1722003791 hasConcept C90924648 @default.
- W1722003791 hasConceptScore W1722003791C121608353 @default.
- W1722003791 hasConceptScore W1722003791C126322002 @default.
- W1722003791 hasConceptScore W1722003791C126894567 @default.
- W1722003791 hasConceptScore W1722003791C141071460 @default.
- W1722003791 hasConceptScore W1722003791C143998085 @default.
- W1722003791 hasConceptScore W1722003791C2775948956 @default.
- W1722003791 hasConceptScore W1722003791C2776694085 @default.
- W1722003791 hasConceptScore W1722003791C2776938808 @default.
- W1722003791 hasConceptScore W1722003791C2778019345 @default.
- W1722003791 hasConceptScore W1722003791C2780624289 @default.
- W1722003791 hasConceptScore W1722003791C2781447364 @default.
- W1722003791 hasConceptScore W1722003791C71315377 @default.
- W1722003791 hasConceptScore W1722003791C71924100 @default.
- W1722003791 hasConceptScore W1722003791C90924648 @default.
- W1722003791 hasIssue "18" @default.
- W1722003791 hasLocation W17220037911 @default.
- W1722003791 hasOpenAccess W1722003791 @default.
- W1722003791 hasPrimaryLocation W17220037911 @default.
- W1722003791 hasRelatedWork W1722003791 @default.
- W1722003791 hasRelatedWork W1814660981 @default.
- W1722003791 hasRelatedWork W1970301117 @default.
- W1722003791 hasRelatedWork W2045803500 @default.
- W1722003791 hasRelatedWork W2074018814 @default.
- W1722003791 hasRelatedWork W2138245006 @default.
- W1722003791 hasRelatedWork W2165887065 @default.
- W1722003791 hasRelatedWork W2409507842 @default.
- W1722003791 hasRelatedWork W2411001802 @default.
- W1722003791 hasRelatedWork W28865151 @default.
- W1722003791 hasVolume "50" @default.
- W1722003791 isParatext "false" @default.